In a previous in vitro study in human glioma cells, we found that IFN-β markedly enhances chemosensitivity to TMZ [24]; this finding suggests that one of the major mechanisms by which IFN-β enhances chemosensitivity is the downregulation of MGMT transcription via p53 induction. The gene discussed is IFNB1; the disease is glioma.